Notes from the SNP vs. haplotype front
- 1 February 2001
- journal article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 2 (1) , 7-10
- https://doi.org/10.1517/14622416.2.1.7
Abstract
Single nucleotide polymorphisms (SNPs) and haplotypes are commonly used genetic markers in clinical studies. We provide some broad guidelines for deciding which of the two is most appropriate in particular circumstances. Molecular haplotyping techniques are also briefly reviewed and contrasted with electronic approaches.Keywords
This publication has 20 references indexed in Scilit:
- The relative power of SNPs and haplotype as genetic markers for association testsPharmacogenomics, 2001
- Complex promoter and coding region β 2 -adrenergic receptor haplotypes alter receptor expression and predict in vivo responsivenessProceedings of the National Academy of Sciences, 2000
- Thiopurine methyltransferase polymorphic tandem repeat: Genotype-phenotype correlation analysisClinical Pharmacology & Therapeutics, 2000
- Genotyping:The predictive power of haplotypes in clinical responsePharmacogenomics, 2000
- Single-nucleotide polymorphisms, haplotypes, and their relevance to pharmacogeneticsMolecular Diagnosis, 1999
- Haplotype Structure and Population Genetic Inferences from Nucleotide-Sequence Variation in Human Lipoprotein LipaseAmerican Journal of Human Genetics, 1998
- Mutation detection and single-molecule counting using isothermal rolling-circle amplificationNature Genetics, 1998
- Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms*Clinical Pharmacology & Therapeutics, 1997
- Rapid molecular haplotyping of the first exon of the human dopamine D4 receptor gene by heteroduplex analysisAmerican Journal of Medical Genetics, 1997
- Direct haplotyping of chromosomal segments from multiple heterozygotes via allele-specific PCR amplificationNucleic Acids Research, 1989